Recent Finacing
Recent Raise
Spero Therapeutics is a Cambridge-based biopharmaceutical company developing small-molecule Potentiator and anti-virulence programs (e.g., SPR741, SPR994, SPR720) to enhance antibiotic efficacy against drug-resistant Gram-negative infections.
